CLL-1029: A Network Meta-Analysis of Efficacy of Zanubrutinib vs Fixed-Duration Acalabrutinib Plus Venetoclax in Treatment-Naïve Chronic Lymphocytic LeukemiaMazyar Shadman, Talha Munir, Rhys Williams et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0